Microarray
微阵列
基本信息
- 批准号:7630235
- 负责人:
- 金额:$ 22.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AlgorithmsAnalysis of VarianceArchivesArtsBehaviorBioinformaticsBiological AssayBiophysicsBiostatistics Shared ResourceBudgetsCanadaCancer Center Support GrantCapillary ElectrophoresisChargeClinicalClinical ResearchCluster AnalysisCollaborationsColorComplementary DNAComputer WorkstationsComputer softwareConditionConsultationsControlled StudyCustomDNADataData AnalysesData Storage and RetrievalDatabasesDiseaseDoctor of PhilosophyEnsureEquipmentEvaluationExperimental DesignsFacultyFee-for-Service PlansFloorFundingGene ExpressionGenesGeneticGenetic ProgrammingGenomeGenotypeGermanyGoalsGrantGraphHandHistocompatibility TestingHourHousekeeping GeneHuman ResourcesImageImage AnalysisInformation StorageInstitutionJournalsLabelLaboratoriesLinear ModelsMalignant NeoplasmsManufacturer NameMeasurementMeasuresMedicalMethodsMicroarray AnalysisMicroarray Shared ResourceModelingMolecular BiologyMolecular ProfilingMutationNatureNebraskaNeuro-Oncological Ventral Antigen 2New MexicoNew YorkNorth CarolinaNucleotidesNumbersOhioOligonucleotidesPatientsPolymerase Chain ReactionPortugalPriceProceduresProcessProductionProtocols documentationPublicationsQuality ControlRNARNA ProcessingRNA analysisRandomizedRateRecommendationRegression AnalysisRelative (related person)Reliability of ResultsReproducibilityResearchResearch InfrastructureResearch PersonnelResource SharingReverse Transcriptase Polymerase Chain ReactionRunningSamplingScanningSchemeScienceSensoryServicesSiteStandards of Weights and MeasuresStructureSumSurveysSwitzerlandSystemTechnologyTestingThe Comprehensive Cancer Center Arthur G James Cancer Hospital and Richard J Solove Research Institute at Ohio State UniversityTimeTissue-Specific Gene ExpressionTranscriptUniversitiesValidationWashingtonWeekWilcoxon Rank TestWorkanticancer researchbasebeta Actinbiomedical informaticscancer geneticscostdata miningdaydesignimprovedinterestinvestigator trainingmemberposterspreferenceprofessorprogramsresearch facilityresearch studystatisticstool
项目摘要
Parallel analysis of multiple genes on the DNA or RNA level is becoming more and more important, because
cancer is identified as a disease that involves multiple genes. To study this cascade of genetic alterations,
analysis on a single-gene level cannot be the final answer. Microarray analysis is state-of-the-art technology for
fulfilling these scientific needs. The OSUCCC Microarray Shared Resource (MASR) was established as a
"developing" Shared Resource in 1998 initially serving investigators in the Molecular Biology and Cancer Genetics
Program with genome wide expression analysis, and subsequently becoming one of the Shared Resources for
the entire OSUCCC offering genome wide expression analysis using Affymetrix GeneChips. In September 2002,
quantification of RNA integrity by capillary electrophoresis became available, and since September 2003, the
MASR has offered validation of microarray results, via an array-based design of primers for real-time PCR. For
projects utilizing any of these technologies, the MASR offers multiple services, including experimental design
consultation, sample processing, hybridization, scanning, full statistical analysis and consultation, and validation
of results. Newer services, such as custom arrays and SNPs are soon to be available. The MASR trains
investigators to upload their results to Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) since this
becomes mandatory for publication in many journals. The MASR website (www.dnaarrays.org) contains
information about services, publications and downloadable protocols and order forms. The MASR offers timely,
technical and professional expertise that promotes high quality science at a competitive price. To support
OSUCCC researchers, several hundred RNA samples are processed each year for genome wide expression
analysis. In addition, several hundred RNA samples are processed for integrity quantification. During 2003, the
MASR worked with 30 investigators, 95% of who are CCC members affiliated with four CCC programs, and the
amount of MASR service to these members increased 72% over the previous year. There are 42 current or
pending grants from OSUCCC members that include utilization of the MASR. The OSUCCC has provided $2.1 M
in Institutional support to establish and run the MASR as a "developing" Shared Resource. We now request
CCSG funding that will provide `30% of the total support for this important full Shared Resource over the next five
years.
在DNA或RNA水平上对多个基因的平行分析变得越来越重要,因为
癌症被确定为涉及多种基因的疾病。为了研究这种一系列遗传改变,
对单基因级别的分析不能成为最终答案。微阵列分析是最先进的技术
满足这些科学需求。 OSUCCC微阵列共享资源(MASR)被确定为
1998年,“开发”共享资源最初为分子生物学和癌症遗传学的研究者提供服务
具有基因组广泛表达分析的程序,随后成为共享资源之一
整个OSUCCC使用Affymetrix Genechips提供基因组广泛的表达分析。 2002年9月,
可用毛细管电泳对RNA完整性的定量,自2003年9月以来
MASR通过基于阵列的实时PCR的引物设计提供了微阵列结果的验证。为了
使用这些技术中的任何一项,MASR提供多种服务,包括实验设计
咨询,样本处理,杂交,扫描,完整的统计分析和咨询以及验证
结果。较新的服务,例如自定义阵列和SNP,即将提供。 MASR火车
研究人员将其结果上传到基因表达综合(http://www.ncbi.nlm.nlm.nih.gov/geo/)之后
在许多期刊上都必须出版。 MASR网站(www.dnaarrays.org)包含
有关服务,出版物和可下载协议和订单表格的信息。 MASR及时提供
技术和专业专业知识,以竞争性的价格促进高质量的科学。支持
OSUCCC研究人员,每年处理几百个RNA样品以进行基因组范围的表达
分析。此外,处理了几百个RNA样品以进行完整性定量。在2003年
MASR与30名调查员合作,其中95%是CCC成员隶属于四个CCC计划,
这些成员的MASR服务数量比上一年增加了72%。有42个电流或
在OSUCCC成员的赠款中,包括使用MASR。 OSUCCC提供了$ 2.1 m
在机构支持中,将MASR作为“开发”共享资源建立和运行。我们现在要求
CCSG资金将在接下来的五个中提供对这一重要共享资源的总支持的30%
年。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALBERT DE LA CHAPELLE其他文献
ALBERT DE LA CHAPELLE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALBERT DE LA CHAPELLE', 18)}}的其他基金
Low-Penetrance Genes in the Predisposition to Papillary Thyroid Cancer
低外显率基因易患甲状腺乳头状癌
- 批准号:
8588543 - 财政年份:2013
- 资助金额:
$ 22.89万 - 项目类别:
Early Predisposing Genes and Risk Stratification for CLL
CLL 的早期易感基因和风险分层
- 批准号:
7715167 - 财政年份:2009
- 资助金额:
$ 22.89万 - 项目类别:
Genes in the Predisposition to Papillary Thyroid Carcinoma
甲状腺乳头状癌易感基因
- 批准号:
8505963 - 财政年份:2008
- 资助金额:
$ 22.89万 - 项目类别:
Genes in the Predisposition to Papillary Thyroid Carcinoma
甲状腺乳头状癌易感基因
- 批准号:
8697753 - 财政年份:2008
- 资助金额:
$ 22.89万 - 项目类别:
Genes in the Predisposition to Papillary Thyroid Carcinoma
甲状腺乳头状癌易感基因
- 批准号:
9246459 - 财政年份:2008
- 资助金额:
$ 22.89万 - 项目类别:
相似国自然基金
网络外部性和随机需求下的供应链风险研究: 基于均值-方差分析
- 批准号:71971224
- 批准年份:2019
- 资助金额:50 万元
- 项目类别:面上项目
企业先做大还是先做强?基于增长导向型战略和利润导向型战略的研究
- 批准号:71902091
- 批准年份:2019
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
基于空间协方差分析建立的AD和SIVD脑灌注模式:生物标志物和机制研究
- 批准号:81870831
- 批准年份:2018
- 资助金额:56.0 万元
- 项目类别:面上项目
基于Copula函数-协方差分析的桥梁群组地震易损性分析方法研究
- 批准号:51808376
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
基于稳健估计方程的联合均值协方差分析及超高维变量筛选
- 批准号:11801466
- 批准年份:2018
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Washington Obstetric-Fetal Pharmacology Research Unit
华盛顿产胎儿药理学研究单位
- 批准号:
7695403 - 财政年份:2004
- 资助金额:
$ 22.89万 - 项目类别: